Joseph M. Miller - 02 Jan 2026 Form 4 Insider Report for Aurinia Pharmaceuticals Inc. (AUPH)

Role
Chief Financial Officer
Signature
/s/ Joseph M. Miller
Issuer symbol
AUPH
Transactions as of
02 Jan 2026
Net transactions value
-$640,568
Form type
4
Filing time
05 Jan 2026, 16:11:21 UTC
Previous filing
04 Mar 2025
Next filing
23 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Miller Joseph M Chief Financial Officer #140, 14315 -118 AVENUE, EDMONTON, ALBERTA, CANADA /s/ Joseph M. Miller 05 Jan 2026 0001746372

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AUPH Common Stock Award $0 +49,038 +8.5% $0.000000 626,399 02 Jan 2026 Direct F1
transaction AUPH Common Stock Tax liability $640,568 -40,161 -6.4% $15.95 589,127 02 Jan 2026 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares earned upon certification of performance for a performance award payable solely in common shares of the Issuer that vest in two (2) equal annual installments on December 31, 2025 and December 31, 2026.
F2 Represents shares withheld to satisfy tax withholding obligations upon the vesting of performance awards.
F3 Includes common shares acquired by the reporting person pursuant to the Issuer's 2021 Employee Share Purchase Plan as follows: 1,721 common shares were acquired on May 30, 2025 and 1,168 common shares were acquired on November 28, 2025.